Loading...
Regenerative Medicine and Gene Therapy
Incubator & Accelerator
Event
Japan Entry Acceleration Program 2025 (JEAP 2025)
Deadline passedApply before Oct 31, 2025
Hybrid (In-person Optional)
About
The Japan Entry Acceleration Program 2025 (JEAP 2025) offers startups in the regenerative medicine and gene therapy sectors a unique opportunity to accelerate their entry into the Japanese market through comprehensive support, including market insights, expert guidance, and a Demo Day to showcase their innovations to potential partners and investors, all at no cost to participants.
Benefits
- Free participation
- Online workshops to understand the Japanese market and prepare for collaboration opportunities
- Online mentoring and business guidance
- Matching meetings with Japanese CDMO/CRO and pharmaceutical companies
- Demo Day to showcase project results to Japanese businesses, investors, and ecosystem partners
Eligibility Criteria
- Startups focused on regenerative medicine, cell therapy, gene therapy, and advanced therapy medicinal products (ATMPs)
- Companies with confirmed clinical development candidates
- Companies interested in entering the Japanese market
- Commitment to participate in multiple online meetings and events
- Ability to attend the Demo Day in Japan and assist with promotional activities
Target Region
Global
Industries
Regenerative Medicine and Gene Therapy